AstraZeneca in Talks with Gilead for a Megamerger

Shots:

• As per Bloomberg, AstraZeneca communicated with Gilead about a possible merger to form the world’s largest drug company. Last month, AstraZeneca approached Gilead to measure its interest in a possible merger
• The merger would unite two of the companies at the forefront of the industry’s efforts to combat COVID-19 and could be politically sensitive as governments seek control over potential vaccines or treatments
• If combined, the two companies would have a market capitalization of ~$232B, which would surpass Merck & Co. and Pfizer at $207B and $200B respectively. Additionally, the deal would exceed BMS’ $74B acquisition of Celgene

Click here to read full press release/ article | Ref: Bloomberg | Image: Bloomberg